Source:
RecallWarning.comFDA Issues Fosamax Alert
Fosamax an osteoporotic prescription drug is in the class of drugs known as bisphosphonates. Fosamax changes the cycle of bone remodeling by slowing down bone loss while bone mass is increased. This drug is used to treat osteoporosis that is steroid-induced or post-menopausal in nature and can also be prescribed for Paget’s disease which is an abnormal bone formation. Fosamax may help to prevent fractures of the wrist, spinal vertebrae and hip. Fosamax has been associated with a number of side effects including osteonecrosis of the jaw (ONJ), severe bone or joint pain, femur fractures and esophageal ulcerations. These Fosamax side effects may be a prelude to a Fosamax Recall. These side effects have initiated a Fosamax Lawsuit against Merck the manufacturer of this osteoporotic drug.
Fosamax Lawsuits Filed A Cross Country
A number of warnings have been added to Fosamax packaging as reports of side effects began to accumulate over time. In 2004, the Food and Drug Administration (FDA) required Merck to include a warning label to alert patients of the risk of ONJ due to reports of the possible link between Fosamax and osteonecrosis of the jaw. Osteonecrosis of the jaw is a destruction of the bone tissue in the jaw that can lead to infection, jawbone breakdown, ulcers in the mouth or osteomyelitis (inflammation of the bone marrow). These reports have brought about a Fosamax Lawsuit involving ONJ. In January of 2008, the FDA issued an alert to inform consumers of the possibility of severe bone, joint and/or muscle pain in consumers taking Fosamax. This pain may occur within day, months or years of taking this osteoporotic drug. These reports have brought about a Fosamax Lawsuit involving bone, joint and muscle pain. Then by April of 2008, new studies were linking Fosamax to serious atrial fibrillation (irregular heart beat) in women. In October 2010, the FDA requested that Merck place a femur fracture warning label be added to all bisphosphonate drugs including Fosamax. However, Merck does not admit to a cause and effect relationship between Fosamax and femur fractures. Although there is evidence that suggests that there is a connection between Fosamax and femur fracture for some time, Merck has still failed to adequately warn consumers of this osteoporotic drug. With all this FDA attention, it is possible that there may be a Fosamax Recall in the near future.
Read more:
http://www.recallwarning.com/fosamax-recall-warning.html
I just found out today, when I tried to refill my prescription and they said they could not do it because the manufacturer had recalled every last pill.